{"public_id":"cl_2ec0e0c278687abf79d08773ee118252","status":"active","superseded_by_public_id":null,"corpus_id":6351267,"text":"Among subjects with mild or moderate renal impairment, both febuxostat doses were more efficacious than allopurinol for reaching serum urate <6.0 mg/dL.","confidence":0.96,"paper":{"corpus_id":6351267,"title":"The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial","url":"https://sah.borca.ai/papers/6351267"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_8916e2ffda698eff3d0fd0d6d838848a","name":"allopurinol","description":"A urate-lowering drug used as the comparator treatment in the trial.","types":["drug","comparator"],"url":"https://sah.borca.ai/concepts/co_8916e2ffda698eff3d0fd0d6d838848a"},{"public_id":"co_9bde39b4d05974eb4e42400d59e05200","name":"mild/moderate renal impairment","description":"Reduced kidney function subgroup analyzed separately for efficacy outcomes.","types":["patient subgroup"],"url":"https://sah.borca.ai/concepts/co_9bde39b4d05974eb4e42400d59e05200"},{"public_id":"co_f28811e5a06df0a82a0469306de171ac","name":"febuxostat","description":"A xanthine oxidase inhibitor used as a urate-lowering medication.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_f28811e5a06df0a82a0469306de171ac"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_2ec0e0c278687abf79d08773ee118252"}